AGP Picks
View all

Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

Press releases published on November 3, 2026

ACT-ion Battery Technologies Celebrates Grand Opening of Cathode Pilot Plant in Carrollton, Texas
Clearsense Named to TIME’s World’s Top HealthTech Companies for the Second Consecutive Year
Septerna to Participate in Upcoming Investor Conferences
Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026
Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
Serenova Re Receives A− Ratings from Rating and Investment Information, Inc. (R&I)
IPG Photonics Announces Third Quarter 2026 Financial Results
Core Molding Technologies Reports Fiscal 2026 Third Quarter Results
CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Dataprana Announces New Brand Identity as It Advances Its Digital Infrastructure Strategy
UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
Atsign Launches EdgeAI to Securely Connect Autonomous Agents, Multi-Cloud Environments, Applications, Physical AI and IoT
Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations
Pensa Launches Retail Execution AI Agent to Streamline Frontline Workforce Activity at Retail
Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026
Sunrun Doubles Puerto Rico Distributed Power Plant Participation as Grid Operator Calls on Home Batteries to Help Prevent Outages
NowVertical Group Announces Third Quarter 2026 Earnings Release Date and Financial Update Webinar
Innventure to Announce Third Quarter 2026 Results on November 12, 2026
Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation
Bond Announces Strategic Financial Realignment, Converting Approximately $15 Million of Debt and Preferred Stock into Equity

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Electronics Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.